Health Level Seven India Successfully Launches First e-Learning Course Offerings

Online program covers the Version 3, Version 2 and Clinical Document Architecture Standards

 Health Level Seven® International (HL7®), the global authority for interoperability and standards in healthcare information technology, recent announced that the HL7 India Affiliate successfully launched the HL7 e-Learning Course (ELC) program. The first session concluded in December 2009 and included students from India, Saudi Arabia and Qatar.

 HL7 International first began offering the e-Learning Course (ELC) in March 2008. Originally developed by the HL7 Argentina Affiliate and offered in Spanish, the course was translated into the English language to accommodate a larger audience. 

Taught by HL7 certified professionals, participants work on real-world exercises to learn how to confront a project involving interoperability among disparate healthcare information systems. They also learn how to read and use the most widely used HL7 standards in the world: Versions 2 and 3, and HL7 Clinical Document Architecture (CDA).

 HL7 designed the course as a self-paced, tutor-assisted model that introduces participants into the concepts of healthcare  interoperability, controlled vocabularies, and HL7 messaging and clinical document standards, from the implementer’s viewpoint.

Course participants learn why they need HL7 standards, when and how to use standards, as well as understanding and experiencing how messages and documents are built and processed.

According to Dr. Supten Sarbadhikari, chair of the Education Committee for HL7 India, the course received positive feedback from the students. “Since there have been further queries for the Course, HL7 India started the second edition of the HL7 ELC in January 2010. All of the students appreciate the thoroughness of the course materials and the prompt and helpful responses from the tutors,” said Dr. Sarbadhikari.

 About HL7 International

 Founded in 1987, Health Level Seven International is the global authority for healthcare Information interoperability and standards with affiliates established in more than 30 countries. HL7 is a non-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7’s more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7 collaborates with other standards developers and provider, payer, philanthropic and government agencies at the highest levels to ensure the development of comprehensive and reliable standards and successful interoperability efforts.

 HL7’s endeavors are sponsored, in part, by the support of its benefactors: Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; European Medicines Agency; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technology; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis Pharmaceuticals Corporation; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; QuadraMed Corporation; Quest Diagnostics Inc.; Siemens Healthcare; St. Jude Medical; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.  Numerous HL7 Affiliates have been established around the globe including Argentina,  Australia, Austria, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, The Netherlands, New Zealand, Romania, Russia, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, and Uruguay.

 For more information, please visit: